In our present study, we have described the crucial role of Fen1 in avoiding replication fork arrest as well as DNA damage upon alovudine treatment, thus implementing alovudine as a possible therapeutic drug for Fen1 deficient cancers. This evidence concerns the gene FEN1 and cancer.